semaglutide glp 1 receptor agonist GLP-1 Agonists as Treatments for Type 2 Diabetes Top GLP-1 Agonists Balance Weight

Advertising-only lead generation remains outside the boundary

PMCID: PMC3044151

INDICATION AND LIMITATIONS OF USE BYDUREON BCise is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus Not recommended as first-line therapy for patients inadequately controlled on diet and exercise Not indicated to treat type 1 diabetes Do not coadminister with other exenatide-containing products Not studied in patients with a history of pancreatitis

The study gave the patients 2 g of acetyl-L-carnitine for 90 days

However, always consult with a healthcare professional if unsure

GLP-1 response varies across patients based on variants in GLP1R, GIPR, FTO, MC4R, and TCF7L2